Screening and analysis of acetyl-cholinesterase (AChE) inhibitors in the context of Alzheimer’s disease
Bhagath Kumar Palaka
Bioinformation, 2018
View PDFchevron_right
Discovery of Novel Acetylcholinesterase Inhibitor Implication for the Design of New Anti-Alzheimer Agents
Amir Zeb
View PDFchevron_right
Insilico Design and Discovery of Some Novel Ache Inhibitors for Treatment of Alzheimer’s Disorder
Manoj Kumar
View PDFchevron_right
Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine
Abdelouahid Samadi
European Journal of Medicinal Chemistry, 2012
View PDFchevron_right
Structure of acetylcholinesterase complexed with (−)-galanthamine at 2.3 Å resolution
alan kozikowski
FEBS Letters, 1999
View PDFchevron_right
Lessons from functional analysis of AChE covalent and noncovalent inhibitors for design of AD therapeutic agents
Chanoch Kronman, Baruch Velan
Chemico-Biological Interactions, 2005
View PDFchevron_right
Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer’s Disease
Amir Zeb
International Journal of Molecular Sciences
View PDFchevron_right
Understanding the quantitative structure–activity relationship of acetylcholinesterase inhibitors for the treatment of Alzheimer's disease
Anuradha Kaplish
View PDFchevron_right
Research Strategies Developed for the Treatment of Alzheimer’s Disease. Reversible and Pseudo-Irreversible Inhibitors of Acetylcholinesterase: Structure-Activity Relationships and Drug Design
MAURICIO ALCOLEA PALAFOX
Frontiers in Drug Design & Discovery, 2014
View PDFchevron_right
New Tacrine−Huperzine A Hybrids (Huprines): Highly Potent Tight-Binding Acetylcholinesterase Inhibitors of Interest for the Treatment of Alzheimer's Disease
Diego Muñoz-torrero, Nuria Vivas, Pelayo Camps
Journal of Medicinal Chemistry, 2000
View PDFchevron_right
Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease
Filip Zemek, Jan Korabecny, V Opletalová, Kamil Kuča
2010
View PDFchevron_right
Dual binding site acetylcholinesterase inhibitors: potential new disease-modifying agents for AD
Diana Fernanda Arana Gordillo
Journal of molecular neuroscience : MN, 2006
View PDFchevron_right
The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer’s Disease
Immacolata Vecchio
Journal of Central Nervous System Disease, 2021
View PDFchevron_right
New Acetylcholinesterase Inhibitors for Alzheimer's Disease
Abdu Adem
International Journal of Alzheimer's Disease, 2012
View PDFchevron_right
Proposing novel natural compounds against Alzheimer's disease targeting acetylcholinesterase
Nigar Çarşıbaşı, Münteha Girgin
Proposing novel natural compounds against Alzheimer’s disease targeting acetylcholinesterase, 2023
View PDFchevron_right
New Acetylcholinesterase Inhibitors for Alzheimer&# 39; s Disease
Abdu Adem
International Journal of Alzheimer's …, 2011
View PDFchevron_right
Synthesis and activity studies of N-[ω-N′-(adamant-1′-yl)aminoalkyl]-2-(4′-dimethylaminophenyl)acetamides: In the search of selective inhibitors for the different molecular forms of acetylcholinesterase
Luciano Cellai
Bioorganic & Medicinal Chemistry Letters, 1998
View PDFchevron_right
Research Article New Acetylcholinesterase Inhibitors for Alzheimer’s Disease
Abdu Adem
View PDFchevron_right
Molecular Modeling and Anticholinesterasic Activity of Novel 2-Arylaminocyclohexyl N,N -Dimethylcarbamates
Simone Aparecida Galerani Mossini, Miguel Junior, Gisele Gauze, Ernani Basso
Journal of the Brazilian Chemical Society, 2013
View PDFchevron_right
Chapter 53: Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease
René Amstutz
Progress in Brain Research, 1993
View PDFchevron_right
Biochemical Studies on a Novel Potent Acetylcholinesterase Inhibitor with Dualsite Binding for Treatment of Alzheimer’s Disease
Nikolai Danchev
2021
View PDFchevron_right
Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates
Lorena Ramirez
Chemico-Biological Interactions, 2010
View PDFchevron_right
Virtual Screening and Admet Analysis for Identification of Inhibitors Against Acetylcholin Esterase Associated with Alzheimer's Disease
Ankit Singh
International Journal of Pharmacy and Pharmaceutical Sciences
View PDFchevron_right
Acetyl cholinesterase: a potential target for Alzheimer’s disease intervention
Sandhya khadka
Journal of Patan Academy of Health Sciences, 2020
View PDFchevron_right